Caligan Partners LP's Form 4 filing
Exelixis, Inc. (EXEL) · filed Nov 29, 2023
- Accession no.
- 0000902664-23-005732
- Filed
- Nov 29, 2023, 4:30 PM ET
- Trade date
- Nov 27, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $2.60M. Open-market sales total $2.60M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Caligan Partners LPCIK 0001727492 | Director |
| Johnson David EdwardCIK 0001785557 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 27, 2023 | Common Stock | SSaleDisposed | −120,409 | $21.61 | −$2,602,038.49 | 790,321 | Indirect | |
| Nov 27, 2023 | Common Stock | PPurchaseAcquired | +120,409 | $21.61 | +$2,602,038.49 | 910,730 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Caligan may be deemed to be a director by deputization of the Issuer by virtue of the fact that Mr. Johnson currently serves on the Issuer's board of directors.